EXHIBIT 99.1

                         18 U.S.C.SECTION 1350,
                         AS ADOPTED PURSUANT TO
              SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Amerimmune Pharmaceuticals,
Inc. (the "Company") on Form 10-QSB for the period ended December 31,
2002, as filed with the Securities and Exchange Commission on the date
hereof (the "Report"), the undersigned certifies, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

     1.   The Report fully complies with the requirements of Section
          13(a) or 15(d) of the Securities Exchange Act of 1934; and

     2.   The information contained in the Report fairly presents, in all
          material respects, the financial condition and results of
          operations of the Company.


/s/ Rex H. Lewis
------------------------
Chief Executive Officer
February 18, 2003